Switching medical devices sourcing from China to Germany

Buyers comparing China and Germany for medical devices are really comparing two very different duty stacks. Goods from China clear at an effective 36.5%, while Germany clears the same category at 11.5% — about $26,375 a year at $100,000 of imports. The duty line moves with paperwork, not production cost, which is why it rewards attention. What follows is the layer-by-layer comparison, the trade context behind each rate, and how the gap grows with volume.

How the tariff stacks compare

Here is how US Customs builds the bill for each origin. A China origin attracts a 1.5% Most-Favoured-Nation base duty, a 25% Section 301 surcharge, and a 10% Section 122 reciprocal surcharge on its medical devices, an effective 36.5% once the $49.74 in processing fees are added. On the Germany side, Customs applies a 1.5% Most-Favoured-Nation base duty and a 10% Section 122 reciprocal surcharge on its medical devices, an effective 11.5% once the $49.74 in processing fees are added. The decisive layer is Section 301: a 25% surcharge that applies only to China-origin goods and sits on top of every other duty, which is why China routes run expensive across so many categories. Section 122 adds a reciprocal duty that one origin escapes via a bilateral deal — a meaningful but expiring factor in the current gap. Processing and harbor fees apply identically whichever country ships the goods ($49.74 here), confirming the saving is pure duty, not fee. Net the two and the duty-and-fee difference is $2,637.50 on a single $10,000 shipment — the 25% effective-rate gap in dollars. Multiply across your volume and it is near $6,594 for $25,000 and about $26,375 for $100,000 a year. A buyer placing $25,000 orders sees about $6,594 of avoidable duty on each one.

Trade context

Within HTS 9018, 9019, 9020, 9021, medical devices includes MRI machines, Ultrasound equipment, Surgical instruments, and Orthopedic implants. For medical devices, where buyers reorder frequently, the duty rate compounds into one of the largest controllable costs on the P&L. China (Asia-Pacific) sends the United States largely consumer electronics, computers servers, and clothing garments. China has no agreement to soften the stack, so its medical devices carries the full column-1 plus surcharge load. Germany (Europe) sends the United States largely passenger vehicles, industrial machinery, and pharmaceuticals. Germany trades under the EU bilateral framework, which shapes the duties on its medical devices. Different regions — Asia-Pacific versus Europe — mean shipping economics deserve a look beside the tariff math. A switch to Germany still hinges on capacity, certification and lead time, but the duty advantage is the part that is already quantified. US tariff policy in 2026 is unusually fluid, with effective rates on many categories changing several times a year — a reason to treat any origin comparison as a live calculation rather than a fixed sheet.

Recommendation

Anchor your own volume to these tiers: $13,188 at $50,000, $65,938 at $250,000, $263,750 at $1,000,000, and about $26,375 at $100,000. All values are calculated, not assumed — the engine applies the current published rates to identical goods and reports the difference. These figures reflect tariff and fee savings only, assuming equal product cost — your actual landed cost also depends on price and freight, which vary by supplier. Read the $26,375 as a transition budget — if re-sourcing to Germany costs less than the annual saving, it pays back inside a year. Diligence on Germany is commercial, not regulatory: supplier capacity, MOQ, tooling and re-qualification cost — the duty advantage itself is already settled above. Because rates move, treat this as a point-in-time read and re-check before committing — especially around the mid-2026 Section 122 expiry. Use the Tariff Savings Finder to test your real numbers and see alternatives beyond Germany. One origin still carries the Section 122 surcharge, due to expire mid-2026; the ranking can shift once it lapses.